The Endothelial GLP-1 Receptor is Critical for the Cardiovascular Protective Effects of GLP-1 (Liraglutide) Treatment in Experimental Arterial Hypertension

被引：0
|
作者：
Helmstadter, Johanna
Filippou, Konstantina
Pawelke, Franziska
Frenis, Katie
Vujacic-Mirski, Ksenija
Kalinovic, Sanela
Kroller-Schon, Swenja
Oelze, Matthias
Munzel, Thomas
Daiber, Andreas
Steven, Sebastian
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A412
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
    Crane, James
    McGowan, Barbara
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (02) : 92 - 107
  • [22] Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
    Torekov, S. S.
    Madsbad, S.
    Holst, J. J.
    OBESITY REVIEWS, 2011, 12 (08) : 593 - 601
  • [23] Activators of the GLP-1 receptor in diabetes treatment
    Holst, JJ
    JOURNAL OF BIOTECHNOLOGY, 2005, 118 : S62 - S63
  • [24] GLP-1 receptor agonists in the treatment of obesity
    Disse, E.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2024, 28 (01): : 18 - 21
  • [25] GI Effects of GLP-1 Receptor Agonists
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1690): : 191 - 192
  • [26] Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1
    Hager, Marlies V.
    Clydesdale, Lachlan
    Gellman, Samuel H.
    Sexton, Patrick M.
    Wootten, Denise
    BIOCHEMICAL PHARMACOLOGY, 2017, 136 : 99 - 108
  • [27] Topography of the GLP-1/GLP-1 receptor system in the spinal cord of male mice
    Ruska, Yvette
    Csibi, Andrea
    Doroghazi, Beata
    Szilvasy-Szabo, Anett
    Mohacsik, Petra
    Kornyei, Zsuzsanna
    Denes, Adam
    Kadar, Andrea
    Puskar, Zita
    Hrabovszky, Erik
    Gereben, Balazs
    Wittmann, Gabor
    Fekete, Csaba
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [28] Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor
    Helmstaedter, Johanna
    Keppeler, Karin
    Kuester, Leonie
    Muenzel, Thomas
    Daiber, Andreas
    Steven, Sebastian
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 659 - 676
  • [29] GLP-1 and dual GIP/GLP-1 receptor agonists increase risk of aspiration
    Reactions Weekly, 2025, 2044 (1) : 3 - 3
  • [30] Cardiovascular safety and benefits of GLP-1 receptor agonists
    Dalsgaard, Niels B.
    Bronden, Andreas
    Vilsboll, Tina
    Knop, Filip K.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (03) : 351 - 363
12345